Related Experiment Video
Updated: Jul 10, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
Antiangiogenic therapy: a universal chemosensitization strategy for cancer?
1Sunnybrook Health Sciences Centre, Departments of Medical Biophysics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M4N 3M5, Canada. robert.kerbel@sri.utoronto.ca
Abstract:
For more than 50 years, a major goal of research in cancer therapeutics has been to develop universally effective agents that render cancer cells more sensitive to cytotoxic chemotherapy without substantially increasing toxicity to normal cells. The results of recent clinical trials indicate that certain antiangiogenic drugs may produce this long-sought effect. Here, I describe three distinct mechanisms that may help to explain the chemosensitizing activity of these drugs: normalizing tumor vasculature, preventing rapid tumor cell repopulation, and augmenting the antivascular effects of chemotherapy. I then discuss how these potential mechanisms might be exploited to maximize therapeutic efficacy.
Insights
Certain antiangiogenic drugs show promise in cancer therapy by making cancer cells more sensitive to chemotherapy. These drugs work by normalizing tumor blood vessels, slowing cancer cell growth, and enhancing chemotherapy
Area of Science:
- Oncology
- Cancer Therapeutics
- Drug Development
Background:
- A long-standing goal in cancer research is to find agents that enhance chemotherapy's effectiveness without increasing side effects.
- Recent clinical trials suggest antiangiogenic drugs may achieve this goal.
Purpose of the Study:
- To explain the mechanisms by which antiangiogenic drugs sensitize cancer cells to chemotherapy.
- To discuss strategies for optimizing the therapeutic use of these drugs.
Main Methods:
- Review of existing research and clinical trial data on antiangiogenic drugs and chemotherapy.
- Analysis of proposed biological mechanisms of action.
Main Results:
- Antiangiogenic drugs may chemosensitize tumors through three primary mechanisms: normalizing tumor vasculature, inhibiting rapid tumor cell repopulation, and potentiating chemotherapy's antivascular effects.
- These mechanisms offer potential avenues for improving cancer treatment efficacy.
Conclusions:
- Antiangiogenic drugs represent a promising strategy for enhancing cytotoxic chemotherapy.
- Understanding and exploiting these mechanisms can lead to more effective cancer treatment regimens.
More Related Videos
08:52Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Related Concept Videos
Cancer
The Tumor Microenvironment
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...